Occlusive Retinal Vessels Associated With Intravitreal Aflibercept, 8.0 mg

Key Points

• Retinal vessel occlusion was observed after intravitreal aflibercept injection in one patient.
• The patient had a history of neovascular age-related macular degeneration which may have contributed to the event.
• The occlusion highlights potential adverse effects associated with intravitreal aflibercept treatment.
• Further investigation is needed to assess the risk of occlusive events in similar patients.